Latest Hyperlipidemia Stories
Submission of Application in Japan Marks an Important Milestone in Strategic Partnership With Amgen Astellas BioPharma THOUSAND OAKS, Calif., March 20, 2015 /PRNewswire/ -- Amgen (NASDAQ: AMGN)
Thirteen Presentations Include New Analyses of PCSK9 Inhibitor at Upcoming American Heart Association Scientific Sessions THOUSAND OAKS, Calif., Nov.
THOUSAND OAKS, Calif., Nov. 10, 2014 /PRNewswire/ -- Amgen (NASDAQ: AMGN) today announced that the U.S.
http://www.heartbeatexperts.com/ -- This Flash Report is a top-line view into Heartbeat Experts’ perspectives on stakeholder management
Study Meets Co-Primary Endpoints of LDL Cholesterol Reduction THOUSAND OAKS, Calif., Aug.
Represents First BLA Submission for a PCSK9 Inhibitor THOUSAND OAKS, Calif., Aug.
Agents That Reduce the Incidence of Cardiovascular Adverse Events Remain a Key Unmet Need for Both Physicians and Payers, According to Findings from Decision Resources Group BURLINGTON, Mass.,
Kurt Warner and wife, Brenda, motivate the 71 million Americans living with high cholesterol to win big by committing to heart health NEW YORK, May 29, 2014 /PRNewswire/ -- National heart-health
WILMINGTON, Del., May 6, 2014 /PRNewswire/ -- AstraZeneca (NYSE: AZN) today announced the US Food and Drug Administration
Data suggest lower risk of major adverse cardiovascular events and death, especially in patients with diabetes or prior coronary heart disease ORLANDO, Fla., May 2, 2014 /PRNewswire/ --
- Growing in low tufty patches.